ANI.Quoting government sources, the news agency said that like other countries, the Indian government will also grant indemnity to the companies if they apply for Emergency Use Authorisation (EUA).In another development that would speed up approvals, the Drug Controller General of India (DCGI) has waived the requirement of testing every batch of foreign-made Covid-19 vaccines by the Central Drugs Laboratory, Kasauli and post-launch bridging trials for such firms.The decision came in the backdrop of Pfizer and Cipla putting forth similar demands during negotiations to supply imported vaccines to India.The apex drug controller has said that the vaccines that are already approved by US FDA, EMA, UK MHRA, PMDA Japan or listed in WHO Emergency.